Encompass Health Corp (EHC)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 810,700 842,400 740,800 638,300 539,500 516,000 529,900 548,100 559,600 599,500 609,200 547,600 563,900 536,800 536,900 604,300 612,100 564,300 567,600 572,300
Total assets US$ in thousands 6,102,400 5,964,300 5,860,900 5,747,300 5,636,500 5,475,900 7,082,200 6,944,000 6,864,900 6,721,700 6,612,900 6,542,200 6,445,900 6,610,500 6,502,500 6,137,700 6,080,700 6,386,800 5,812,100 5,583,800
Operating ROA 13.28% 14.12% 12.64% 11.11% 9.57% 9.42% 7.48% 7.89% 8.15% 8.92% 9.21% 8.37% 8.75% 8.12% 8.26% 9.85% 10.07% 8.84% 9.77% 10.25%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $810,700K ÷ $6,102,400K
= 13.28%

To analyze Encompass Health Corp's operating return on assets (operating ROA) over the past eight quarters, we observe a fluctuating trend.

The operating ROA ranged from a low of 10.25% in Q2 2022 to a high of 12.32% in Q3 2022. Overall, the trend shows some variability but generally remains within a relatively narrow band, with the latest quarter, Q4 2023, reporting an operating ROA of 11.99%. This indicates that for each dollar of assets the company has, it generated a return of approximately 11.99 cents from its operating activities at the end of the fourth quarter of 2023.

It is important to further investigate the factors driving these fluctuations in operating ROA to assess the company's operational efficiency and profitability. Additionally, comparing the operating ROA with industry benchmarks and peer companies can provide further insight into Encompass Health Corp's financial performance.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
Encompass Health Corp
EHC
13.28%
Mednax Inc
MD
0.33%
Select Medical Holdings
SEM
7.22%